Pharmacy Daily Advertising

Pharmacy Daily is produced every weekday of the year, except for NSW public holidays and a short break over the Christmas/New Year period. It is circulated by email to more than 12,500 pharmacy industry personnel across Australia and the globe each day, including community pharmacies, hospitals, government agencies, peak pharmacy groups, wholesalers, pharmaceutical manufacturers, students and educational institutions.

The publication is noted for timely, accurate reporting. Advertising produces immediate results and is seen as the most cost-effective way to promote to the Australian pharmacy industry.

Pharmacy Daily consists of a number of A4 pages carrying news stories, photographs and advertising, distributed in Adobe Acrobat PDF format via email. The pages are generally divided into four columns and advertisements can be one, two , three or four columns wide. Full-page advertisements are also accepted as attachments.

Product advertising

A number of pharmacy industry suppliers and organisations promote their products to the industry using Pharmacy Daily. New products, sales promotions, industry services and other items are advertised each day and produce strong results for advertisers.

Therapeutic Goods Advertising Code
The Therapeutic Goods Advertising Code (the Code) ensures that the marketing and advertising of therapeutic goods is conducted in a manner that promotes the quality use of the product, is socially responsible and does not mislead or deceive the consumer. To view the code click here

Job advertising

Because Pharmacy Daily is read by people across the industry every day it’s the ideal place to advertise jobs in community and hospital pharmacy as well as in pharmaceutical manufacturing. Advertising is very affordable and because the newsletter is highly targeted it sees high quality job applicants responding to vacancies. Jobs advertised within the newsletter are also featured on our website for two weeks at no extra cost.

Website advertising

The Pharmacy Daily website is a popular source of information for the industry, containing content such as photos, videos, an industry calendar and the ability to search back issues. Because of Pharmacy Daily’s very strong readership, the newsletter drives traffic to the website, meaning it should be a vital part of the online strategy of any pharmacy industry group wanting to promote to the trade.

To enquire about advertising rates and sizes please complete the form below, email or call our marketing department on 1300 799 220 (within Australia) or +61 2 8007 6760.

Your Name (required)

Your Email (required)







Latest Pharmacy Daily headlines

Wed 26 Jul 17

TGA explains codeine danger

Pharmacy Daily

THE Therapeutic Goods Administration has expanded the information available at its online 'Codeine Hub' (PD 14 Jul), with additional resources available under the heading 'Codeine use can be harmful'.

Wed 26 Jul 17

Blooms Health ad banned

BLOOMS Health has been pinged for promoting online its Coenzyme Q10 150 Max product (pictured) as an "amazing" panacea across a wide range of medical conditions, by the Therapeutic Goods Administration Complaints Resolution Panel (TGACRP).

Tue 25 Jul 17

Deakin to audit hospitals

RESEARCHERS from Deakin University have announced the first infection survey of Australian hospitals in more than 30 years.

Tue 25 Jul 17

Guild lays out codeine position

EXECUTIVE director of the Pharmacy Guild of Australia, David Quilty, has penned an open letter to clarify the Guild's position relating to the up-scheduling of pain relief medicines containing codeine from 01 Feb 2018.

Tue 25 Jul 17

PPA slams Guild attitude

UNION group Professional Pharmacists Australia (PPA) says it's "disappointed by the attitude and obstruction of the Pharmacy Guild of Australia," as part of the PPA response to the Interim Report of the Review of Pharmacy Remuneration and Regulation.

Mon 24 Jul 17

Cannabis concentrate alarm

UNIVERSITY of Queensland (UQ) researchers have expressed concern around the recent legalisation of medicinal cannabis in Australia potentially giving rise to super-potent cannabis concentrates with associated harmful effects.

View All news articles Subscribe to the Newsletter